| Lela Faircloth Allen, PA-C | |
|
3018 N Patterson St, Valdosta, GA 31602-1711 | |
| (229) 433-7200 | |
| (229) 249-4031 |
| Full Name | Lela Faircloth Allen |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 23 Years |
| Location | 3018 N Patterson St, Valdosta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104024777 | NPI | - | NPPES |
| 622508818C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 003754 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Georgia Medical Center | Valdosta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Authority Of Valdosta And Lowndes County Georgia | 1355334509 | 56 |
News Archive
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
Helix BioPharma Corp. today announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix's positive findings from its preliminary non-GLP toxicology studies.
Two studies by neurological researchers at Rush University Medical Center suggest that, in the future, colonic tissue obtained during either colonoscopy or flexible sigmoidoscopy may be used to predict who will develop Parkinson's disease, a neurodegenerative disorder of aging that that leads to progressive deterioration of motor function due to loss of neurons in the brain that produce dopamine, a neurotransmitter essential to executing movement.
For the first time, the American Academy of Pediatrics (AAP) and the American College of Medical Genetics and Genomics (ACMG) spoke with one voice and released a set of recommendations and guidelines on best practices for genetic testing and screening of children.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lela Faircloth Allen, PA-C Po Box 70, Valdosta, GA 31603-0070 Ph: (229) 433-7200 | Lela Faircloth Allen, PA-C 3018 N Patterson St, Valdosta, GA 31602-1711 Ph: (229) 433-7200 |
News Archive
EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.
Helix BioPharma Corp. today announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix's positive findings from its preliminary non-GLP toxicology studies.
Two studies by neurological researchers at Rush University Medical Center suggest that, in the future, colonic tissue obtained during either colonoscopy or flexible sigmoidoscopy may be used to predict who will develop Parkinson's disease, a neurodegenerative disorder of aging that that leads to progressive deterioration of motor function due to loss of neurons in the brain that produce dopamine, a neurotransmitter essential to executing movement.
For the first time, the American Academy of Pediatrics (AAP) and the American College of Medical Genetics and Genomics (ACMG) spoke with one voice and released a set of recommendations and guidelines on best practices for genetic testing and screening of children.
St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.
› Verified 5 days ago
Chaeli Wisenbaker, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2412 N Oak St, Valdosta, GA 31602 Phone: 229-244-1400 Fax: 229-244-5512 | |
Ashly Mcdaniel, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3527 N Valdosta Rd, Valdosta, GA 31602 Phone: 229-247-2290 | |
Mr. Lonas Edward Lewis Ii, P.A.-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3251 Inner Perimeter Rd Ste B, Valdosta, GA 31602 Phone: 229-259-0006 Fax: 229-259-0803 | |
Dana Woods Simpson, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 201 Woodrow Wilson Dr, Valdosta, GA 31602 Phone: 229-241-0041 Fax: 229-241-0048 | |
Matthew Allan Thomas, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2412 N Oak St, Valdosta, GA 31602 Phone: 229-244-1400 Fax: 229-244-5512 | |
Ms. Shonta K Winbush, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 704 Gil Harbin Ind Blvd, Valdosta, GA 31602 Phone: 229-242-9003 Fax: 229-242-0490 |